Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7049389 + RO7020531 in chronic hepatitis B without significant fibrosis
CTR20201678Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2020
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linvencorvir, ruzotolimod in Chronic Hepatitis B (CHB), sponsored by Roche. Started Aug 2020; status: completed.
02
Drugs
linvencorvirruzotolimod
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20201678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201678.